Inventor · disambiguated record
Markus Manz
Also filed as: MANZ MARKUS · MANZ MARKUS G · MANZ MARKUS GABRIEL
29 granted patents·8 pending applications·336 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0197US10433527B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Oct 8, 2019·13 cites·12 claims
- 0297US8847004B2Humanized M-CSF miceMURPHY ANDREW J·Filed 2012·Granted Sep 30, 2014·28 cites·16 claims
- 0397US8692052B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2012·Granted Apr 8, 2014·22 cites·16 claims
- 0497US8541646B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2010·Granted Sep 24, 2013·39 cites·17 claims
- 0596US9986724B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Jun 5, 2018·17 cites·14 claims
- 0696US9655352B2Humanized M-CSF miceREGENERON PHARMA·Filed 2014·Granted May 23, 2017·19 cites·6 claims
- 0796US9554563B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2013·Granted Jan 31, 2017·20 cites·25 claims
- 0896US9301509B2Genetically modified mice and engraftmentSTEVENS SEAN·Filed 2012·Granted Apr 5, 2016·21 cites·18 claims
- 0995US9901082B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Feb 27, 2018·17 cites·6 claims
- 1094US9820476B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2013·Granted Nov 21, 2017·12 cites·15 claims
- 1193US9402377B2Human SIRPAalpha transgenic animals and their methods of useFLAVELL RICHARD A·Filed 2011·Granted Aug 2, 2016·33 cites·10 claims
- 1293US6761883B2Mammalian myeloid progenitor cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2001·Granted Jul 13, 2004·63 cites·6 claims
- 1392US11051499B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2019·Granted Jul 6, 2021·3 cites·20 claims
- 1490US10278374B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2017·Granted May 7, 2019·3 cites·20 claims
- 1589US11026408B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2019·Granted Jun 8, 2021·2 cites·17 claims
- 1689US2025072406A1Humanized M-CSF MiceREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1789US2025072405A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1888US7618654B2Mammalian myeloid progenitor cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2007·Granted Nov 17, 2009·8 cites·11 claims
- 1987US10561126B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Feb 18, 2020·5 cites·22 claims
- 2086US2024099278A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2183US10123518B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2016·Granted Nov 13, 2018·3 cites·28 claims
- 2281US7300760B2Mammalian myeloid progenitor cell subsetsUNIV LELAND STANFORD JUNIOR·Filed 2003·Granted Nov 27, 2007·6 cites·6 claims
- 2377US12402611B2Genetically modified mice and engraftmentREGENERON PHARMA·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 2477US12127537B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2021·Granted Oct 29, 2024·0 cites·18 claims
- 2577US2023292721A1Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2674US12127536B2Humanized M-CSF miceREGENERON PHARMA·Filed 2020·Granted Oct 29, 2024·0 cites·21 claims
- 2774US11778995B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Oct 10, 2023·0 cites·11 claims
- 2874US10463028B2Genetically modified non-human animals expressing human EPOREGENERON PHARMA·Filed 2015·Granted Nov 5, 2019·1 cites·19 claims
- 2974US9839208B2Human SIRPα transgenic mice and their methods of useUNIV YALE·Filed 2016·Granted Dec 12, 2017·1 cites·17 claims
- 3069US10785968B2Genetically modified non-human animals and methods of use thereofREGENERON PHARMA·Filed 2017·Granted Sep 29, 2020·0 cites·10 claims
- 3167US10785966B2Humanized M-CSF miceREGENERON PHARMA·Filed 2017·Granted Sep 29, 2020·0 cites·11 claims
- 3264US2018020647A1Genetically Modified Non-Human Animals And Methods Of Use ThereofREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 3364US2024074414A1Genetically modified non-human animals expressing human epoREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 3462US11576356B2Genetically modified non-human animals and methods of use thereofREGENEREN PHARMACEUTICALS INC·Filed 2020·Granted Feb 14, 2023·0 cites·20 claims
- 3559US11766032B2Genetically modified non-human animals expressing human EPOREGENERON PHARMA·Filed 2019·Granted Sep 26, 2023·0 cites·9 claims
- 3656US2024141043A1Bispecific antibody that binds to cd3 and a fluorophoreETH ZUERICH·Filed 2022·Application pending·0 cites
- 3750US2022315653A1BISPECIFIC BINDING AGENT THAT BINDS TO CD117/c-KIT AND CD3UNIV ZUERICH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Manz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →